Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
Venugopala KN, Chandrashekharappa S, Pillay M, Abdallah HH, Mahomoodally FM, Bhandary S, Chopra D, Attimarad M, Aldhubiab BE, Nair AB, Sreeharsha N, Morsy MA, Pottathil S, Venugopala R, Odhav B, Mlisana K. Venugopala KN, et al. Among authors: mlisana k. PLoS One. 2019 Jun 4;14(6):e0217270. doi: 10.1371/journal.pone.0217270. eCollection 2019. PLoS One. 2019. PMID: 31163040 Free PMC article.
Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
OʼDonnell MR, Pillay M, Pillay M, Werner L, Master I, Wolf A, Mathema B, Coovadia YM, Mlisana K, Horsburgh CR, Padayatchi N. OʼDonnell MR, et al. Among authors: mlisana k. J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):536-43. doi: 10.1097/QAI.0000000000000650. J Acquir Immune Defic Syndr. 2015. PMID: 25886924 Free PMC article.
Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.
Venugopala KN, Dharma Rao GB, Bhandary S, Pillay M, Chopra D, Aldhubiab BE, Attimarad M, Alwassil OI, Harsha S, Mlisana K. Venugopala KN, et al. Among authors: mlisana k. Drug Des Devel Ther. 2016 Aug 25;10:2681-90. doi: 10.2147/DDDT.S109760. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27601885 Free PMC article.
Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
Venugopala KN, Chandrashekharappa S, Pillay M, Bhandary S, Kandeel M, Mahomoodally FM, Morsy MA, Chopra D, Aldhubiab BE, Attimarad M, Alwassil OI, Harsha S, Mlisana K, Odhav B. Venugopala KN, et al. Among authors: mlisana k. Med Chem. 2019;15(3):311-326. doi: 10.2174/1573406414666180703121815. Med Chem. 2019. PMID: 29968540
In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against Mycobacterium tuberculosis.
Venugopala KN, Tratrat C, Pillay M, Chandrashekharappa S, Al-Attraqchi OHA, Aldhubiab BE, Attimarad M, Alwassil OI, Nair AB, Sreeharsha N, Venugopala R, Morsy MA, Haroun M, Kumalo HM, Odhav B, Mlisana K. Venugopala KN, et al. Among authors: mlisana k. Drug Des Devel Ther. 2020 Mar 9;14:1027-1039. doi: 10.2147/DDDT.S228381. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32214795 Free PMC article.
Pyrazinamide resistance in rifampicin discordant tuberculosis.
Mvelase NR, Singh R, Swe Swe-Han K, Mlisana KP. Mvelase NR, et al. Among authors: mlisana kp. PLoS One. 2022 Sep 21;17(9):e0274688. doi: 10.1371/journal.pone.0274688. eCollection 2022. PLoS One. 2022. PMID: 36129921 Free PMC article.
195 results